Jordan University of Science and Technology

ACGME International Continues to Grow, Begins Accreditation Activities in Vietnam

Retrieved on: 
Thursday, August 10, 2023

ACGME-I accreditation activities expand to 12 countries as VinUni College of Health Sciences in Hanoi becomes the first Sponsoring Institution in Vietnam to achieve ACGME-I accreditation.

Key Points: 
  • ACGME-I accreditation activities expand to 12 countries as VinUni College of Health Sciences in Hanoi becomes the first Sponsoring Institution in Vietnam to achieve ACGME-I accreditation.
  • Finally, GME programs in two long-standing Sponsoring Institutions in Qatar – dermatology at Hamad Medical Corporation and pediatric anesthesiology at Sidra Medicine – also achieved Initial Accreditation.
  • Over the past five years, ACGME-I accreditation activities have grown significantly, doubling the number of countries and accredited GME programs.
  • Its mission is to improve health care by assessing and advancing the quality of resident physicians’ education through accreditation.

HAYA Therapeutics Adds World-Leading Cardiologist and Dark Genome Pioneer to Advisory Boards

Retrieved on: 
Thursday, February 16, 2023

HAYA Therapeutics, SA , a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs (lncRNAs), today announced that Ahmad Masri, M.D., M.S.

Key Points: 
  • HAYA Therapeutics, SA , a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs (lncRNAs), today announced that Ahmad Masri, M.D., M.S.
  • View the full release here: https://www.businesswire.com/news/home/20230216005353/en/
    Dr. Ahmad Masri, a Cardiologist and Physician Scientist at the Oregon Health & Science University’s Knight Cardiovascular Institute, has been named the newest member of HAYA Therapeutic’s Clinical Advisory Board.
  • (Photo: Business Wire)
    “The expansion of our advisors with Ahmad and Cedric, and the creation of our Clinical Advisory Board marks a significant milestone for HAYA,” said Samir Ounzain, Ph.D., Co-founder and CEO of HAYA Therapeutics.
  • “HAYA has pioneered a novel approach of targeting disease drivers within the dark genome, and I’m looking forward to working with their team in identifying and understanding relevant clinically-translatable dark genome targets.”

New Academic Leaders: Strategies for Success Online Course - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 29, 2022

The "New Academic Leaders: Strategies for Success" training has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "New Academic Leaders: Strategies for Success" training has been added to ResearchAndMarkets.com's offering.
  • New Academic Leaders: Strategies for Success is a Online Course designed to help new leaders capitalize on their opportunities as change agents, and manage the challenges that arise in any position involving oversight of faculty.
  • New Academic Leaders: Strategies for Success is a Online Course designed to help new leaders capitalize on their opportunities as change agents, and manage the challenges that arise in any position involving oversight of faculty.
  • At the conclusion of New Academic Leaders: Strategies for Success, participants will have gained the knowledge and insight to:
    Create an environment of civility, collaboration, and respect
    New Academic Leaders: Strategies for Success provides a roadmap for impactful leadership based on sound strategic thinking, careful planning, and committed relationship-building.

Animal health giant introduces vaccine in Middle East and North Africa to control foot-and-mouth disease and improve livestock productivity

Retrieved on: 
Thursday, May 19, 2022

The seminar "Foot and Mouth Disease status in the Middle East" was attended by authorities who are responsible of protecting the health status of a region which has an estimated 1 billion heads of livestock, between sheep, goats, cattle and camelids.

Key Points: 
  • The seminar "Foot and Mouth Disease status in the Middle East" was attended by authorities who are responsible of protecting the health status of a region which has an estimated 1 billion heads of livestock, between sheep, goats, cattle and camelids.
  • "Biognesis Bags vaccine will be key to protecting the region's animal health status and productivity.
  • Dr. Esteban Turic, CEO at Biogenesis Bag, also emphasized about the region's main animal health issues and the company's approach towards working together for its control.
  • Biognesis Bag is an international biotechnology company with more than 80 years of experience, specialized in the development, production, and commercialization of products for animal health and productivity.